BioSpace News Archive

Biotech Bay

Titan Pharmaceuticals Receives $5.9 Million From Exercise Of Warrants

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) today announced that, since January 1, 2020 , it has received proceeds of approximately $5.9 million as a result of the exercise of approximately 26.2 million previously issued Class B common share purchase warrants (the “Class B Warrants”).

March 5, 2020
·
3 min read
Pharm Country

Quest Diagnostics to Launch Coronavirus Disease 2019 (COVID-19) Test

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced it will launch a coronavirus (COVID-19) test service.

March 5, 2020
·
2 min read
Job Trends

ClinOne Announces Award for Coordinator of the Month for January 2020

ClinOne is proud to announce our Coordinator of the Month award recipient for January 2020.

March 5, 2020
·
2 min read
Biotech Bay

Health Gorilla becomes largest CommonWell Connector™ through new partnerships

Health Gorilla, a leader in clinical data APIs, today announced that they have successfully connected more than a dozen healthcare organizations to the CommonWell Health Alliance® network.

March 5, 2020
·
3 min read
Canndoc and Super-Pharm Sign Long-Term Partnership Agreement

announces today that wholly owned subsidiary, Canndoc, has entered into a strategic partnership agreement with Super-Pharm, Israel’s leading and largest drugstore chain.

March 5, 2020
·
3 min read
Biotech Beach

Institute for Women’s and Children’s Health Launched at The Lundquist Institute

New institute brings together renowned experts focused on biggest health concerns facing women and children

March 5, 2020
·
4 min read
BioCapital

ViTel Net announces turnkey solutions for COVID-19 mitigation

COVID-19 has become a global topic of concern, and effective remote patient care is needed more than ever.

March 5, 2020
·
2 min read
Business

The Alliance for Regenerative Medicine Releases 2019 Annual Report and Sector Year in Review

Second highest year for global financings in regenerative medicine, with nearly $10 billion raised globally Washington, DC, March 05, 2020 .

March 5, 2020
·
3 min read
Zydus Announces World’s First Drug for the Treatment of Non-Cirrhotic NASH

Saroglitazar, approved by DCGI becomes the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoholic SteatoHepatitis

March 5, 2020
·
3 min read
Business

March Of Dimes Welcomes Andrew S. Coccari, Jr. As Chief Development Officer

March of Dimes, the leading nonprofit fighting for the health of moms and babies, today announced the appointment of Andrew S. Coccari, Jr. as Chief Development Officer, responsible to transform its fundraising activities and to strengthen, broaden, and diversify its revenue mix.

March 5, 2020
·
2 min read